Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Verve Therapeutics Inc’s stock clocked out at $4.37, down -5.62% from its previous closing price of $4.63. In other words, the price has decreased by -$5.62 from its previous closing price. On the day, 2.35 million shares were traded.
Ratios:
To gain a deeper understanding of VERV’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.84 and its Current Ratio is at 9.84. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.12.
On April 08, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.
On April 13, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $29.Canaccord Genuity initiated its Buy rating on April 13, 2023, with a $29 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 02 ’25 when Kathiresan Sekar sold 9,822 shares for $4.15 per share. The transaction valued at 40,761 led to the insider holds 346,686 shares of the business.
Nickerson Joan sold 2,777 shares of VERV for $11,525 on Apr 02 ’25. The Chief Administrative Officer now owns 17,420 shares after completing the transaction at $4.15 per share. On Apr 02 ’25, another insider, Ashe Andrew D., who serves as the insider of the company, sold 2,681 shares for $4.15 each. As a result, the insider received 11,126 and left with 348,828 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 6.54 while its Price-to-Book (P/B) ratio in mrq is 0.82.
Stock Price History:
Over the past 52 weeks, VERV has reached a high of $9.31, while it has fallen to a 52-week low of $2.86. The 50-Day Moving Average of the stock is -10.71%, while the 200-Day Moving Average is calculated to be -23.46%.
Shares Statistics:
A total of 88.80M shares are outstanding, with a floating share count of 65.76M. Insiders hold about 26.23% of the company’s shares, while institutions hold 73.78% stake in the company.
